| Oct 30 2024 |
This Week in 340B: October 22 – 28, 2024 |
McDermott Will & Emery |
| Oct 30 2024 |
Stakeholders Raise 340B Concerns in Medicaid Drug Rebate Program Final Rule; CMS, With Hands Tied, Shrugs |
Mintz |
| Oct 30 2024 |
Importance of Negotiating Exclusivity, Expansion and Relocation Provisions in Health Care Leases |
Epstein Becker & Green, P.C. |
| Oct 30 2024 |
Michigan Employers: Get Ready for Expanded Paid Sick Leave |
Epstein Becker & Green, P.C. |
| Oct 29 2024 |
The Privacy and Data Security Impact of California’s Recent AI Bills |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 29 2024 |
OSHA Enforcement Memo for Animal Slaughtering and Meat Processing Industries Portends In-Depth, Lengthy Investigations |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 29 2024 |
D.C.’s Certificate of Need (CON) Process Could See Improvement with Proposed Legislation |
Epstein Becker & Green, P.C. |
| Oct 29 2024 |
Safety Perspectives From the Dallas Region: Tipping the Scale —Strategies for Working with Compliance Officers [Podcast] |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 29 2024 |
BRight Minds in Healthcare Delivery: Episode 11- Empowering Physicians & Provider Groups as they Navigate the Transition to Value-Based Care [Podcast] |
Blank Rome LLP |
| Oct 29 2024 |
Election 2024: Gender-Affirming Care in the US |
McDermott Will & Emery |
| Oct 28 2024 |
Are You Ready? Deadline to Comply with HIPAA Requirements for Reproductive Health Care PHI December 23, 2024 |
Squire Patton Boggs (US) LLP |
| Oct 28 2024 |
What a Headache: The Third Circuit Finds That a Plaintiff’s Migraines Were Not a Serious Health Condition Under the FMLA |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 28 2024 |
Here Comes Mandatory COVID-19 Testing by Employers (But Not for Antibodies) |
Foley & Lardner LLP |
| Oct 28 2024 |
MASSACHUSETTS PRIVACY LAW CLARIFIED: Website Tracking Escapes Wiretap Act Scrutiny |
Troutman Amin, LLP |
| Oct 28 2024 |
Update: Federal and State Agencies Release Telehealth-Related Updates |
Bradley Arant Boult Cummings LLP |
| Oct 26 2024 |
Beltway Buzz, October 25, 2024 |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 25 2024 |
Illinois Passes New Physical Therapy Law HB 5087 |
McDermott Will & Emery |
| Oct 25 2024 |
Massachusetts Supreme Judicial Court Rejects Wiretap Claims Based on Website Tracking |
Pierce Atwood LLP |
| Oct 25 2024 |
The Essentials—California Employment Law Update for 2025 |
K&L Gates LLP |
| Oct 25 2024 |
Investors, Researchers, and Business Leaders Take Note: $110M Awarded to Advance Women’s Health |
Epstein Becker & Green, P.C. |
| Oct 25 2024 |
Trending in Telehealth: October 14 – 21, 2024 |
McDermott Will & Emery |
| Oct 25 2024 |
San Diego Physician and Medical Practice Pay $3.8 Million to Resolve FCA Allegations |
ArentFox Schiff LLP |
| Oct 25 2024 |
General Assembly Approves Second Round of Hurricane Helene Relief |
Ward and Smith, P.A. |
| Oct 24 2024 |
Illinois Health Care Facilities Immune from Ordinary Negligence Liability for Care Provided While Assisting the State During COVID-19 Pandemic |
Much Shelist, P.C. |
| Oct 24 2024 |
PRIVACY TIP #418 – New Phishing Scheme Uses Scarce Weight Loss Drugs as Hook |
Robinson & Cole LLP |
| Oct 24 2024 |
Microsoft Report Highlights Attacks Against Healthcare Organizations |
Robinson & Cole LLP |
| Oct 24 2024 |
States Fill Gaps in Hospital Workplace Violence Laws—Requiring Law Enforcement Officers, Weapons Detection Screening Policies in Hospitals, and More |
Epstein Becker & Green, P.C. |
| Oct 24 2024 |
Employment Law Changes Are Coming! |
Katten |
| Oct 24 2024 |
Safety Basics VII: Whistleblower Protections [Podcast] |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 24 2024 |
The Abiomed Impella Litigation: What Patients and Families Need to Know |
Oberheiden P.C. |
| Oct 24 2024 |
All Things Chemical® Podcast: A Conversation with Linda Reinstein, President and Cofounder of the Asbestos Disease Awareness Organization (ADAO) [Podcast] |
Bergeson & Campbell, P.C. |
| Oct 24 2024 |
This Week in 340B: October 15 – 21, 2024 |
McDermott Will & Emery |
| Oct 23 2024 |
Private Equity Investments in Oncology: Top Five Things to Know |
Foley & Lardner LLP |
| Oct 23 2024 |
GLP-1 Drugs: FDA Sued Over Removing Tirzepatide from the Drug Shortage List |
Foley & Lardner LLP |
| Oct 23 2024 |
Federal District Court in Florida Holds FCA’s Qui Tam Provisions Unconstitutional |
Bradley Arant Boult Cummings LLP |
